Published July 22, 2026
Pfizer has reached a tentative framework to resolve thousands of federal lawsuits brought by women who developed meningioma — a tumor that grows in the tissue surrounding the brain or spinal cord — after using the birth control injection Depo-Provera. As of early July 2026, roughly 5,830 cases were pending in the federal multidistrict litigation, according to legal industry reporting.
It's important to be clear about what this settlement is, and isn't, at this stage. It's a framework, not a finalized payout — the specific financial terms and eligibility requirements for individual claimants haven't been made public. Pfizer has not admitted wrongdoing and continues to maintain that the drug is safe. For women already pursuing a claim, a resolved framework can still mean their case moves toward resolution faster than a full trial process typically would.
One detail that's easy to miss in headlines: this settlement only covers cases filed in the federal MDL. State court cases run on an entirely separate track, with their own procedural rules and deadlines. Delaware, for example, currently has hundreds of Depo-Provera cases proceeding through its state court system, unaffected by whatever the federal settlement ultimately looks like. Legal commentary on this point has emphasized that a federal resolution in one venue simply doesn't reach claims filed in another.
That distinction matters most for anyone who hasn't filed yet. Filing deadlines (statutes of limitation) are set at the state level and run independently of the federal settlement timeline — waiting to "see how the settlement turns out" isn't a safe strategy if your own state's deadline is approaching.
If you used Depo-Provera for an extended period and were later diagnosed with a meningioma, the practical next step is the same regardless of how the federal settlement resolves: get a free eligibility review sooner rather than later, so an attorney familiar with both the federal and state landscape can look at your specific timeline. See Atumio's Depo-Provera case page for a free, no-obligation review, or start your case review directly.